Posted inCorporate Updates
Morepen Enters U.S. Prescription Generics Market with the Launch of its Desloratadine Tablets, Complementing Broader API, R&D and CDMO Growth Strategy
Morepen Laboratories Limited announced the launch of its first prescription (Rx) generic product, Desloratadine Tablets USP, 5 mg, in 100-count and 500-count packs, for distribution in the U.S. market. The…






